Related references
Note: Only part of the references are listed.Estrogen Receptor Activation Protects Against TNF-α-Induced Endothelial Dysfunction
Daniela Palmieri et al.
ANGIOLOGY (2014)
Heart Disease and Stroke Statistics-2014 Update A Report From the American Heart Association
Alan S. Go et al.
CIRCULATION (2014)
Atherosclerotic Plaque Destabilization Mechanisms, Models, and Therapeutic Strategies
Carlos Silvestre-Roig et al.
CIRCULATION RESEARCH (2014)
Relieving the cardiometabolic disease burden: a perspective on phytometabolite functional and chemical annotation for diabetes management
David R. Janero
EXPERT OPINION ON PHARMACOTHERAPY (2014)
Comparative pharmacokinetics and tissue distribution analysis of systemically administered 17-β-estradiol and its metabolites in vivo delivered using a cationic nanoemulsion or a peptide-modified nanoemulsion system for targeting atherosclerosis
Dipti Deshpande et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Hormones and Cardiovascular Disease in Older Men
Bu B. Yeap et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2014)
Endothelial estrogen receptor isoforms and cardiovascular disease
Kyung Hee Kim et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Nox4 NADPH oxidase contributes to smooth muscle cell phenotypes associated with unstable atherosclerotic plaques
Shaoping Xu et al.
REDOX BIOLOGY (2014)
Effects of dietary flaxseed on atherosclerotic plaque regression
Andrew A. Francis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, double blind, placebo controlled trials
Manuela Casula et al.
ATHEROSCLEROSIS SUPPLEMENTS (2013)
Cholesterol and atherosclerosis: modulation by oestrogen
Matthias Barton
CURRENT OPINION IN LIPIDOLOGY (2013)
Therapeutic gene targeting approaches for the treatment of dyslipidemias and atherosclerosis
Petri I. Makinen et al.
CURRENT OPINION IN LIPIDOLOGY (2013)
Current evidence and future perspectives of omega-3 polyunsaturated fatty acids for the prevention of cardiovascular disease
Evangelos C. Rizos et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Engineering of an ω-3 polyunsaturated fatty acid-containing nanoemulsion system for combination C6-ceramide and 17β-estradiol delivery and bioactivity in human vascular endothelial and smooth muscle cells
Dipti Deshpande et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2013)
Therapeutic potential of the nitrite-generated NO pathway in vascular dysfunction
Michael Madigan et al.
FRONTIERS IN IMMUNOLOGY (2013)
Biochemistry, Physiology, and Pathophysiology of NADPH Oxidases in the Cardiovascular System
Bernard Lassegue et al.
CIRCULATION RESEARCH (2012)
Impacts of Nanoparticles on Cardiovascular Diseases: Modulating Metabolism and Function of Endothelial Cells
Jie Meng et al.
CURRENT DRUG METABOLISM (2012)
The Role of An Experimental Model of Atherosclerosis: apoE-knockout Mice in Developing New Drugs against Atherogenesis
Jacek Jawien
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
Nanoparticle delivery for transdermal HRT
Pilar Valenzuela et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2012)
Nanomedicine for the prevention, treatment and imaging of atherosclerosis
Costas Psarros et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2012)
Estrogen and the cardiovascular system
A. A. Knowlton et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial
Louise Lind Schierbeck et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Nanomedicine in cardiovascular therapy: recent advancements
Ziyad Mohammed Binsalamah et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2012)
Therapeutic strategies for endothelial dysfunction
Dipti D. Deshpande et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2011)
Using omega-3 fatty acids in the practice of clinical lipidology
W. Virgil Brown et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2011)
Omega-3 Fatty Acids and Cardiovascular Disease Effects on Risk Factors, Molecular Pathways, and Clinical Events
Dariush Mozaffarian et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Specific penetration and accumulation of a homing peptide within atherosclerotic plaques of apolipoprotein E-deficient mice
Juliana Hamzah et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Omega-3 fatty acids and metabolic syndrome: Effects and emerging mechanisms of action
Hemant Poudyal et al.
PROGRESS IN LIPID RESEARCH (2011)
Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques
Shann S. Yu et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2011)
The cardiovascular effects of flaxseed and its omega-3 fatty acid, alpha-linolenic acid
Delfin Rodriguez-Leyva et al.
CANADIAN JOURNAL OF CARDIOLOGY (2010)
Insights into Atherosclerosis Using Nanotechnology
Ashwath Jayagopal et al.
CURRENT ATHEROSCLEROSIS REPORTS (2010)
Complex Regulation and Function of the Inflammatory Smooth Muscle Cell Phenotype in Atherosclerosis
Anthony Wayne Orr et al.
JOURNAL OF VASCULAR RESEARCH (2010)
Hormonal modulation of endothelial NO production
Sue P. Duckles et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2010)
Nitric oxide and oxidative stress in vascular disease
Ulrich Foerstermann
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2010)
Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases
Biana Godin et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Experimental and clinical research findings on the cardiovascular benefits of consuming flaxseed
Chantal M. C. Bassett et al.
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM (2009)
Functional Role of CD11c+ Monocytes in Atherogenesis Associated With Hypercholesterolemia
Huaizhu Wu et al.
CIRCULATION (2009)
SELP and SELPLG Genetic Variation Is Associated with Cell Surface Measures of SELP and SELPLG: The Atherosclerosis Risk in Communities Carotid MRI Study
Kelly A. Volcik et al.
CLINICAL CHEMISTRY (2009)
Increased Risk for Atherosclerosis of Various Macrophage Scavenger Receptor 1 Alleles
Ronen Durst et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2009)
Inflammation in Atherosclerosis From Pathophysiology to Practice
Peter Libby et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Pleiotropic, Cardioprotective Effects of Omega-3 Polyunsaturated Fatty Acids
Pawel Petkow Dimitrow et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2009)
Estrogen-Eluting Stents
Sung Kee Ryu et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2009)
Vascular actions of estrogens: Functional implications
Virginia M. Miller et al.
PHARMACOLOGICAL REVIEWS (2008)
Atherosclerosis-prone hemodynamics differentially regulates endothelial and smooth muscle cell phenotypes and promotes pro-inflammatory priming
Nicole E. Hastings et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Dietary flaxseed inhibits atherosclerosis in the LDL receptor-deficient mouse in part through antiproliferative and anti-inflammatory actions
Chantal M. C. Dupasquier et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Nitric oxide and atherosclerosis: An update
Claudio Napoli et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2006)
Effects of dietary flaxseed on vascular contractile function and atherosclerosis during prolonged hypercholesterolemia in rabbits
C. M. C. Dupasquier et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Gender differences of cardiovascular disease - New perspectives for estrogen receptor signaling
Matthias R. Meyer et al.
HYPERTENSION (2006)
Involvement of ICAM-1 in the progression of atherosclerosis in APOE-knockout mice
K Kitagawa et al.
ATHEROSCLEROSIS (2002)
Low-dose estrogen supplementation improves vascular function in hypogonadal men
PA Komesaroff et al.
HYPERTENSION (2001)
Share Paper
